HIV Drug Suit Against Gilead, BMS And Janssen Trimmed
A California federal judge dismissed attempts to revive allegations of an antitrust conspiracy involving Gilead, Bristol-Myers Squibb and Janssen Pharmaceuticals to block generic competition and keep HIV medication prices artificially high...To view the full article, register now.
Already a subscriber? Click here to view full article